Medicine and Health Sciences Commons^™

Does Supplementation With Vitamin D And Calcium Reduce The Risk Of Developing Pre-Eclampsia Compared With Prophylactic Daily Aspirin Use?, Katja Berge

Physician Assistant Scholarly Project Posters

Pre-eclampsia is a hypertensive disorder that occurs during pregnancy. Onset is typically around the 20 week of gestation and serious complications may occur if it is not properly managed. Complications from pre-eclampsia include preterm delivery, disease progression to eclampsia, organ damage, placental abruption, and neonatal complications. Initial management involves the use of antihypertensive medications. Current guidelines recommend the initiation of 81 mg aspirin starting at 12 weeks gestation for women with increased risk factors. The goal of this literature review is to examine the effectiveness of calcium and vitamin D supplementation compared to daily prophylactic aspirin use for prevention of …

Aspirin Vs. Pravastatin For Prevention Of Preterm Delivery In Patients At Risk For Pre-Eclampsia, Mary Weisberg

Physician Assistant Scholarly Project Posters

This literature review is an examination of the use of low-dose aspirin therapy versus the use of pravastatin therapy to prevent preterm delivery in women at risk of developing preeclampsia. Preeclampsia is defined as new onset hypertension after 20 weeks of gestation with evidence of maternal organ or uteroplacental dysfunction or proteinuria. Preeclampsia is a serious condition that affects pregnant women and their growing fetuses which may lead to maternal or fetal demise. The Prevention of preeclampsia with the use of low-dose aspirin in the first 12-16 weeks is currently the mainstay of treatment for women with moderate to severe …

Review Of Anticoagulation Therapy In Unprovoked Pulmonary Embolism, Christopher D. Klucas

Physician Assistant Scholarly Project Posters

The purpose of this research was to identify the best course of action in response to a diagnosis of unprovoked pulmonary embolism.

•The evidence demonstrates non-inferiority status of new direct oral anticoagulants (DOAC) when indirectly compared to conventional warfarin therapy.

•Aspirin was also found effective in mitigating the risk of recurrence, but to a lesser extent than both DOAC agents and warfarin.

•DOACs are reasonable alternatives to conventional therapy. Attention to individual comorbidities may allow providers to find advantage with one therapy over another.

• The research, thus far, has not been able to identify a universally safe and an …